What is it about?
Human studies of DNA and rRNA sequences are related to Parkinson's disease (PD) and Multiple System Atrophy (MSA). These human findings were compared to results in PD and MSA mouse models. We found that there were similarities between humans and mice and that our drugs improved bacterial pools in some of the aging mice.
Featured Image
Photo by Ryan Stone on Unsplash
Why is it important?
These findings are important because they may identify markers for PD and MSA diagnosis and show that our novel drugs improve mouse bacterial pools in the gut.
Perspectives
I hope this article makes people think deeply about important health concerns that are related to diseases of aging, as people are living longer in all parts of the world ... but longer is not always living better. It is exciting to think that our new drugs have the potential to help cure PD and MSA. Mostly, I hope you will find our work thought-provoking and that we will soon move the drugs to clinical trials.
Ruth Perez
R & R Perez LLC
Read the Original
This page is a summary of: A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models, Journal of Parkinson’s Disease, January 2020, IOS Press,
DOI: 10.3233/jpd-191693.
You can read the full text:
Contributors
The following have contributed to this page
